Yes, foreign-invested enterprises (FIEs) in China can access the 100% R&D super-deduction on the same basis as domestic Chinese companies, provided they meet the same qualifying activity and documentation requirements. The incentive, formally known as the “Additional Pre-Tax Deduction of Enterprise R&D Expenses” (企业研发费用加计扣除, qǐyè yánfā fèiyòng jiājì kòuchú), is governed by Caishui [2023] No. 7 and applies to all resident enterprises — defined under CIT Law Article 2 as enterprises established in China under Chinese law, which includes wholly foreign-owned enterprises (WFOEs), Sino-foreign joint ventures, and foreign-invested partnerships. The deduction rate was increased from 75% to 100% in 2023 and has been extended through December 31, 2027. There is no separate track for domestic versus foreign companies — any enterprise with qualifying R&D activities can claim the 200% deduction (100% original expense + 100% additional deduction) on eligible expenditure.
Regulatory Basis for FIE Eligibility
The eligibility of FIEs for the R&D super-deduction is established through multiple legal instruments. The PRC Corporate Income Tax Law (企业所得税法, Qǐyè Suǒdé Shuì Fǎ) Article 30 provides the statutory basis for R&D expense deductions. The implementing regulation (CIT Law Implementation Regulations, Article 95) specifically defines “enterprise” for R&D purposes without distinguishing between domestic and foreign-invested entities. Caishui [2023] No. 7, which enacts the 100% super-deduction level, applies to “all enterprises” with qualifying R&D expenditure — the language is explicitly inclusive.
The State Taxation Administration (国家税务总局, Guójiā Shuìwù Zǒngjú) has issued multiple circulars confirming FIE eligibility, including STA Announcement [2021] No. 28 (which governs the filing process) and Guoshuifa [2017] No. 39 (the negative list of non-qualifying activities). None of these contain any restriction based on foreign ownership, capital structure, or ultimate beneficial owner nationality.
However, there are two important nuances for FIEs: (1) cross-border outsourced R&D is capped at 80% of expenditure (Caishui [2018] No. 64), and (2) transfer pricing adjustments can reduce the effective benefit if related-party transactions are not at arm’s length (CIT Law Chapter 6).
What R&D Activities Qualify for the Super-Deduction
The qualifying activity definition applies uniformly to FIEs and domestic companies. Under Guoshuifa [2023] No. 7, qualifying R&D is defined as “systematic and creative activities with clear technical objectives, undertaken to acquire new scientific or technical knowledge, or to create new or substantially improved products, processes, or services.”
| Activity Type | Qualifies? | FIE-Specific Note |
|---|---|---|
| New product development (in China) | Yes | Standard qualification — must demonstrate technical novelty |
| Adapting foreign technology to China | Yes | Qualifies if adaptation involves technical risk and experimental work |
| Process improvement for Chinese factories | Yes | Qualifies if improvement is substantial (e.g., ≥15% efficiency gain) |
| Software development for China market | Yes | Qualifies if new functionality, not just localization |
| Routine testing / QC | No | Standard exclusion — regardless of ownership |
| Market research / consumer surveys | No | Standard exclusion — not technical activity |
| Cosmetic product modifications | No | Standard exclusion — no technical novelty |
| Foreign R&D directed from HQ | Conditional | Qualifies if Chinese entity performs the experimental work and bears technical risk |
Foreign companies should note that adapting foreign-developed technology for the Chinese market does qualify for the super-deduction, provided the adaptation involves genuine technical risk and experimentation — for example, reformulating a chemical process to use locally available raw materials with different impurity profiles, or redesigning a product to meet Chinese technical standards (GB standards) where the modification requires engineering analysis, prototyping, and testing.
Expense Categories: Same Rules for FIEs
FIEs claim the super-deduction on exactly the same six expense categories as domestic companies, with the critical addition of cross-border outsourcing restrictions:
| Expense Category | FIE Deduction Rate | Key FIE Consideration |
|---|---|---|
| R&D personnel costs (salaries, bonuses, social insurance) | 100% super-deduction | Foreign employees on Chinese payroll qualify; seconded staff not on Chinese payroll do not |
| Direct materials and prototypes | 100% super-deduction | Imported materials used in R&D qualify if consumed in China |
| Depreciation of R&D equipment | 100% super-deduction | Equipment partly used for production must be allocated proportionally |
| Design and testing fees | 100% super-deduction | Fees paid to Chinese third-party labs qualify at 100% |
| Domestic outsourced R&D | 100% super-deduction | Contract with Chinese third-party R&D provider; full deduction applies |
| Cross-border outsourced R&D | 80% super-deduction | R&D performed outside mainland China by related or unrelated parties — capped at 80% |
| Other direct costs (travel, patent fees) | 100% super-deduction | Must be project-specific, not general overhead |
The 80% cap on cross-border outsourced R&D is the single most important distinction for FIEs. Under Caishui [2018] No. 64, if a Chinese WFOE contracts with its overseas parent company (or any third party outside mainland China) for R&D services, only 80% of the contract value qualifies for the super-deduction. For a WFOE that outsources RMB 5 million in R&D to its German parent, the super-deduction applies to RMB 4 million (80%) rather than RMB 5 million — meaning the total deduction is RMB 9 million (5M × 80% × 200%), not RMB 10 million.
Common FIE-Specific Challenges
While FIEs are eligible on paper, several practical challenges can reduce or eliminate the benefit:
- Seconded foreign staff costs — Foreign employees who are on the payroll of the overseas parent company (rather than the Chinese WFOE) cannot be included in the Chinese entity’s R&D personnel costs. To qualify, the foreign employee must have a formal employment contract with the Chinese entity, be on the Chinese payroll, and be registered in the Chinese social insurance system. Secondment agreements without direct employment create a documentation gap that routinely triggers disallowance.
- IP ownership and technology import restrictions — Under the PRC Technology Import and Export Administration Regulations, Chinese companies importing technology from foreign entities must register the technology import contract with MOFCOM. If the Chinese FIE is performing R&D to adapt imported technology, the technology import registration must be in place for the related R&D costs to be eligible. Unregistered technology imports are a common documentation failure in FIE R&D deduction claims.
- Transfer pricing adjustment risk — As detailed in the Transfer Pricing compliance guide for tax incentive users, the STA closely scrutinizes FIEs claiming the R&D super-deduction while paying significant royalties or service fees to overseas related parties. If the Chinese entity claims RMB 10 million in R&D expenses while paying RMB 8 million in royalties to its Hong Kong parent, the tax authority may question whether the R&D is genuinely performed in China or recycled through related-party arrangements. In 2025, the STA’s Special Tax Adjustment unit initiated 23 audits specifically targeting FIE R&D deduction claims with high related-party royalty payments.
- R&D personnel qualification issues — FIE R&D teams often include a mix of local hires and foreign secondees. Under the HTE certification rules, R&D personnel must account for ≥10% of total headcount. If the FIE’s foreign staff are not counted (because they are not on the Chinese payroll), the headcount ratio may fall below the threshold, indirectly affecting the R&D deduction’s perceived legitimacy — even though the R&D deduction itself has no headcount ratio requirement.
- Documentation language — The R&D project plans, technical reports, and experimental records must be maintained in Chinese. FIEs that keep their primary technical documentation in English must prepare Chinese summaries or translations for tax inspection purposes. While English-language documentation is not invalid per se, STA inspectors in practice prefer Chinese-language records and may request translation for any document they cannot readily review.
Documentation Requirements Specific to FIEs
Beyond the standard R&D deduction documentation, FIEs should prepare the following additional records to strengthen their claim:
- Employment contracts for foreign R&D staff — Signed with the Chinese entity, not a secondment company or overseas employer. Must specify the R&D role, responsibilities, and work location in China.
- Technology import registration certificates — If the R&D involves adapting imported technology, the MOFCOM technology import registration (技术进口合同登记证书, jìshù jìnkǒu hétóng dēngjì zhèngshū) must be on file before the R&D costs are incurred.
- Cross-border R&D contracts with Chinese-language versions — For outsourced R&D performed outside China, the contract must be available in Chinese and must specify the technical scope, deliverables timeline, and IP ownership terms.
- Related-party transaction documentation — If the Chinese FIE has cross-border related-party transactions, the contemporaneous transfer pricing documentation must address how the R&D deduction interacts with the arm’s length pricing of related-party services and technology transfers.
- Physical presence records for foreign R&D staff — Entry-exit records showing that foreign R&D personnel claiming to work in China were physically present for the relevant period. Remote R&D work performed outside China by foreign staff on Chinese payroll raises substance questions.
Quantifying the FIE R&D Benefit
To understand the real-world value of the R&D super-deduction for a foreign company, consider a mid-sized WFOE in Shanghai that incurs RMB 8 million in qualifying R&D expenses annually, with RMB 6 million domestic and RMB 2 million cross-border outsourced:
| Component | Amount (RMB) |
|---|---|
| Domestic R&D expense | 6,000,000 |
| Cross-border R&D expense (80% qualifies) | 1,600,000 |
| Total qualifying expenditure | 7,600,000 |
| Super-deduction (100% additional) | 7,600,000 |
| Total deduction on CIT return | 15,200,000 |
| Tax saving at 25% CIT rate | 3,800,000 |
| Tax saving at 15% HTE rate | 2,280,000 |
For a WFOE paying the standard 25% CIT rate, the R&D super-deduction saves RMB 3.8 million annually on RMB 8 million of R&D spend — a 47.5% effective subsidy rate on the original expenditure. Even with the 80% cross-border cap on RMB 2 million, the total benefit remains substantial. Combining the R&D deduction with HTE certification (15% CIT rate) reduces the tax saving proportionally but still provides meaningful support for the company’s China R&D operations.
FIE R&D Super-Deduction Compliance Checklist
Follow this ordered checklist to ensure your foreign company can successfully claim the R&D super-deduction in 2026:
- Confirm FIE eligibility — Verify your Chinese entity is a resident enterprise under CIT Law Article 2. WFOEs, JVs, and FIPEs all qualify. Rep offices do not qualify as they are not resident enterprises for CIT purposes.
- Separate domestic and cross-border R&D spend — Track R&D expenditure by location of the service provider. Domestic R&D qualifies at 100%; cross-border outsourced R&D at 80%. Document the location of R&D performance (not just the contract counterparty’s registration address).
- Ensure foreign R&D staff are on Chinese payroll — Seconded employees must have direct employment contracts with the Chinese entity, be on the Chinese payroll, and be registered in China’s social insurance system. Secondment agreements alone are insufficient.
- Register technology import contracts with MOFCOM — If R&D involves adapting imported technology, register the technology import contract before incurring R&D costs. Unregistered imports create a documentation gap that can result in full disallowance.
- Prepare Chinese-language R&D documentation — Maintain project plans, technical reports, and expenditure records in Chinese. If primary documentation is in English, prepare Chinese summaries or certified translations for each R&D project.
- Prepare contemporaneous transfer pricing documentation — If the FIE has related-party transactions (royalties, service fees, interest), ensure the local file addresses the R&D deduction’s impact on arm’s length pricing. File the related-party transaction form with the annual CIT return.
- Create the R&D expense subsidiary ledger — The R&D expense auxiliary ledger (研发支出辅助账) must be prepared and attached to the annual CIT return. Use the STA’s standard template format (available on the e-tax platform).
- File the super-deduction claim on the annual CIT return — Complete Schedule A107012 (R&D Expense Additional Deduction Table) as part of the annual CIT filing. Ensure the deduction amounts match the subsidiary ledger and supporting invoices.
Where to Go From Here
Based on what you just read:
- Ready to act? Read [guide: SLUG-TO-BE-FILLED]
- Still comparing? See [comparison: SLUG-TO-BE-FILLED]
- Need numbers? Try [tool: SLUG-TO-BE-FILLED]
— China Gateway 360 —
Remote China market entry support, built around execution.
